Publications by authors named "Merce Roget"

Claim this Profile
E
Evolving epidemiology of HCC in Spain.
Margarita Sala, Sonia Pascual, Maria Rosa Rota Roca, Ana María Matilla, Marta Campos, Mercè Roget

JHEP Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy.
Joan Martínez-Campreciós, Mar Riveiro-Barciela, Raquel Muñoz-Gómez, María-Carlota Londoño, Mercé Roget

Gastroenterol Hepatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma.
Anna Soria, Mariona Calvo, Meritxell Casas, Zara Vidales, Sergio Muñoz-Martínez, Mercè Roget

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current trends in access to treatment for hepatitis B in immigrants vs non-immigrants.
Mireia Miquel, Albert Pardo, Montse Forné, Gemma Martínez-Alpin, Adrià Rodríguez-Castellano, Mercè Roget

Gastroenterol Rep (Oxf)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study.
María-Carlota Londoño, Mar Riveiro-Barciela, Adriana Ahumada, Raquel Muñoz-Gómez, Mercé Roget

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.
Qian Chen, Celia Perales, María Eugenia Soria, Damir García-Cehic, Josep Gregori, Mercè Roget

Antiviral Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of survival and prognostic factors in treatment of hepatocellular carcinoma in Spanish patients with drug-eluting bead transarterial chemoembolization.
Jordi Sánchez-Delgado, Mercedes Vergara, Salvador Machlab, Alba Lira, Carlos Gómez Zaragoza, Mercè Roget

Eur J Gastroenterol Hepatol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients.
Jordi Navarro, Montserrat Laguno, Helem Haydee Vilchez, Jose M Guardiola, Jose A Carrion, Mercè Roget

J Antimicrob Chemother· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease.
Sabela Lens, Inmaculada Fernández, Sergio Rodríguez-Tajes, Vanessa Hontangas, Mercedes Vergara, Merce Roget

Am J Gastroenterol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis.
Ferran Cereto, Xavier Herranz, Eva Moreno, Antònia Andreu, Mertxe Vergara, Mercè Roget

Eur J Gastroenterol Hepatol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a study of prolonging treatment with pegylated interferon-alpha2a plus ribavirin in HIV/HCV-coinfected patients with no early virological response.
Daniel Fuster, Ramon Planas, Juan Gonzalez, Luís Force, Manel Cervantes, Mercè Roget

Antivir Ther· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis